Repurposing is an exciting approach to drug development; it involves looking at existing medicines, and testing them to see if they could be effective in treating Duchenne Muscular Dystrophy.

Our host Clare Runacres speaks to Emily Crossley, Duchenne UK Co-founder, and Professor Dirk Fischer, from UKBB, the University Children’s Hospital in Basel, Switzerland about the work we are doing on repurposing medicines.

If you have any questions or would like to get in touch please email [email protected] or visit www.duchenneuk.org